b 213 750 Pill - white capsule/oblong
Pill with imprint b 213 750 is White, Capsule/Oblong and has been identified as Niacin Extended-Release 750 mg. It is supplied by Teva Pharmaceuticals USA Inc.
Niacin is used in the treatment of High Cholesterol; Pellagra; Dietary Supplementation; Niacin Deficiency; Hyperlipoproteinemia Type IV, Elevated VLDL and belongs to the drug classes miscellaneous antihyperlipidemic agents, vitamins. Risk cannot be ruled out during pregnancy. Niacin 750 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for b 213 750
Niacin Extended-Release
- Imprint
- b 213 750
- Strength
- 750 mg
- Color
- White
- Shape
- Capsule/Oblong
- Availability
- Rx and/or OTC
- Drug Class
- Miscellaneous antihyperlipidemic agents, Vitamins
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA Inc.
- National Drug Code (NDC)
- 00093-7393 (Discontinued)
- Inactive Ingredients
-
povidone k90,
stearic acid
Note: Inactive ingredients may vary.
More about niacin
- Check interactions
- Compare alternatives
- Reviews (117)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Support group
- Drug class: miscellaneous antihyperlipidemic agents
Patient resources
Other brands
Niaspan, Slo-Niacin, Niacor, Nicotinex, ... +5 more
Professional resources
- Niacin (Antilipemic) monograph
- Niacin, Niacinamide (Vitamin) (AHFS Monograph)
- Niacin (FDA)
- Niacin Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.